Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies

INTRODUCTION: The impact of psoriasis varies with the body region affected. In addition, patients have different perceptions of disease improvement and treatment satisfaction based on the location of skin clearance with treatment. The monoclonal antibody secukinumab selectively targets interleukin-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Menter, Alan, Cather, Jennifer C., Jarratt, Michael, Meng, Xiangyi, Guana, Adriana, Nyirady, Judit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120629/
https://www.ncbi.nlm.nih.gov/pubmed/27576559
http://dx.doi.org/10.1007/s13555-016-0140-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120629/
https://www.ncbi.nlm.nih.gov/pubmed/27576559
http://dx.doi.org/10.1007/s13555-016-0140-7

Ejemplares similares